Foghorn Therapeutics raises $50 million in January financing Mar 11, 2026 04:10PM
Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook Mar 11, 2026 04:09PM
Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium Jan 13, 2026 04:05PM
Foghorn Therapeutics Provides Second Quarter 2024 Financial and Corporate Update Aug 8, 2024 07:00AM
Foghorn Therapeutics Raises Approximately $110 Million Through Registered Direct Offering to Advance Pipeline May 22, 2024 06:21PM